Brown Advisory Inc
Source: SEC Form 13F · as of Mar 2026Brown Advisory Inc holds 21 biotech & pharma companies tracked by BioSniper, totaling $197.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$197.0M
BioSniper AIPage evidence connected
Prepared research question
What matters most for ALNYLAM PHARMACEUTICALS, INC. (ALNY)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ALNYALNYLAM PHARMACEUTICALS, INC. | 133,953 | $44.3M |
| CYTKCYTOKINETICS INC | 614,655 | $40.5M |
| GILDGILEAD SCIENCES, INC. | 256,313 | $35.7M |
| SNYSanofi | 622,613 | $30.0M |
| PCVXVaxcyte, Inc. | 511,701 | $29.7M |
| INSMINSMED Inc | 22,949 | $3.8M |
| ANIPANI PHARMACEUTICALS INC | 47,250 | $3.6M |
| REGNREGENERON PHARMACEUTICALS, INC. | 3,264 | $2.5M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 34,155 | $1.9M |
| IONSIONIS PHARMACEUTICALS INC | 15,105 | $1.1M |
| OCULOCULAR THERAPEUTIX, INC | 90,000 | $762K |
| MRNAModerna, Inc. | 13,344 | $678K |
| FOLDAMICUS THERAPEUTICS, INC. | 45,525 | $658K |
| SYRESpyre Therapeutics, Inc. | 12,400 | $625K |
| PVLAPALVELLA THERAPEUTICS, INC. | 4,769 | $594K |
| IBRXImmunityBio, Inc. | 19,801 | $152K |
| SVRASavara Inc | 20,854 | $114K |
| OGNOrganon & Co. | 13,347 | $80K |
| BCDABioCardia, Inc. | 35,538 | $43K |
| ELUTELUTIA INC. | 20,135 | $21K |
| HUMAHumacyte Inc. | 13,129 | $8K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.